Skip to main content

Human Health

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative healthcare products.

Humanpharma

Further Topics

HF_infographic_card

Heart Diseases

Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide.

View this Section
pexels-photo-6942000

Metabolic Diseases

About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. This number is projected to increase to 629 million people by 2045.

View this Section
lib_org_D3pZd677

Cancer

Cancer takes. Takes away time. Takes away loved ones. At Boehringer Ingelheim we are providing new hope for patients by taking cancer on.

View this Section
Image 8 (1)

Lung Diseases

Boehringer Ingelheim has 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area.

View this Section
Our_responsibility

Skin Diseases

Living with inflammatory and fibrotic diseases greatly impacts patients’ lives, both physically and emotionally. These patients guide and inspire us to turn innovative science into life-changing medical breakthroughs.

View this Section
young-man-schizo

Mental Disorders

Central nervous system (CNS) diseases, including schizophrenia or Alzheimer’s disease, are a focus of Boehringer Ingelheim discovery research and development.

View this Section
Retinal Health Landing Page

Retinal Diseases

At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases. Visual impairment and blindness have a profound and devastating impact on the lives of the affected person.

View this Section